Ruxolitinib Combined With Vorinostat Suppresses Tumor Growth and Alters Metabolic Phenotype in Hematological Diseases
Oncotarget - United States
doi 10.18632/oncotarget.21951
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 23, 2017
Authors
Publisher
Impact Journals, LLC